X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3134) 3134
Newsletter (43) 43
Book Chapter (33) 33
Magazine Article (29) 29
Newspaper Article (15) 15
Reference (11) 11
Book / eBook (7) 7
Government Document (3) 3
Book Review (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2100) 2100
science & technology (2051) 2051
life sciences & biomedicine (1988) 1988
thalidomide - pharmacology (1454) 1454
thalidomide (1396) 1396
animals (1052) 1052
thalidomide - analogs & derivatives (999) 999
thalidomide - therapeutic use (942) 942
male (893) 893
female (850) 850
pharmacology & pharmacy (798) 798
oncology (579) 579
multiple myeloma - drug therapy (510) 510
thalidomide - adverse effects (466) 466
thalidomide - administration & dosage (460) 460
multiple myeloma (437) 437
mice (436) 436
middle aged (434) 434
aged (398) 398
adult (365) 365
lenalidomide (333) 333
hematology (331) 331
antineoplastic agents - pharmacology (295) 295
antineoplastic agents - therapeutic use (288) 288
rats (274) 274
aids/hiv (261) 261
treatment outcome (261) 261
angiogenesis inhibitors - pharmacology (260) 260
research (252) 252
antineoplastic combined chemotherapy protocols - therapeutic use (242) 242
dose-response relationship, drug (220) 220
cell line, tumor (213) 213
immunosuppressive agents - pharmacology (203) 203
angiogenesis inhibitors - therapeutic use (196) 196
pregnancy (194) 194
medicine & public health (192) 192
drug therapy (188) 188
immunology (185) 185
bortezomib (184) 184
care and treatment (181) 181
multiple myeloma - pathology (181) 181
thalidomide - chemistry (177) 177
cancer (176) 176
toxicology (171) 171
clinical trials as topic (168) 168
pharmacology/toxicology (164) 164
analysis (163) 163
apoptosis - drug effects (162) 162
pharmacology (162) 162
immunosuppressive agents - therapeutic use (160) 160
cells, cultured (159) 159
angiogenesis (157) 157
disease models, animal (148) 148
biochemistry & molecular biology (142) 142
abridged index medicus (141) 141
cell proliferation - drug effects (137) 137
tumor necrosis factor-alpha - antagonists & inhibitors (136) 136
aged, 80 and over (133) 133
chemistry (133) 133
thalidomide - pharmacokinetics (133) 133
immunologic factors - therapeutic use (132) 132
tumor necrosis factor-alpha - metabolism (128) 128
health aspects (126) 126
immunologic factors - pharmacology (126) 126
time factors (126) 126
dexamethasone - administration & dosage (121) 121
medicine, research & experimental (119) 119
research & experimental medicine (119) 119
chemistry, medicinal (118) 118
apoptosis (117) 117
cell biology (113) 113
physical sciences (113) 113
multiple myeloma - metabolism (109) 109
chemotherapy (103) 103
neoplasms - drug therapy (103) 103
inflammation (101) 101
thalidomide - metabolism (101) 101
antineoplastic agents - adverse effects (99) 99
thalidomide - toxicity (99) 99
abnormalities, drug-induced (98) 98
administration, oral (98) 98
rabbits (97) 97
dosage and administration (96) 96
dermatology (95) 95
dexamethasone (95) 95
cytokines (94) 94
myelodysplastic syndromes - drug therapy (88) 88
drugs (87) 87
antineoplastic combined chemotherapy protocols - adverse effects (86) 86
drug synergism (86) 86
immunomodulation (84) 84
old medline (84) 84
recurrence (84) 84
angiogenesis inhibitors (83) 83
tumor necrosis factor-alpha - biosynthesis (83) 83
internal medicine (82) 82
antineoplastic agents - administration & dosage (81) 81
disease-free survival (80) 80
drug therapy, combination (80) 80
signal transduction - drug effects (80) 80
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
East Asian (Cheng Yu Tung) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Robarts - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3078) 3078
German (82) 82
Japanese (68) 68
French (37) 37
Chinese (33) 33
Italian (23) 23
Spanish (16) 16
Portuguese (12) 12
Dutch (8) 8
Russian (5) 5
Polish (4) 4
Czech (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Hungarian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 1528-0020, 11/2011, Volume 118, Issue 18, pp. 4771 - 4779
Journal Article
Blood, ISSN 0006-4971, 04/2013, Volume 121, Issue 15, pp. 2975 - 2987
Journal Article
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2014, Volume 40, Issue 9, pp. 1080 - 1088
Highlights • PTCL has a poor prognosis; existing therapies are insufficient. • We summarize current evidence on novel therapies for relapsed/refractory PTCL. •... 
Hematology, Oncology and Palliative Medicine | Antifolate | Nucleoside analog | Histone deacetylase inhibitor | Fusion protein | Peripheral T-cell lymphoma | Immunomodulatory agent | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Interleukin-2 - therapeutic use | Neoplasm Recurrence, Local - drug therapy | Antineoplastic Agents - therapeutic use | Cyclophosphamide - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Folic Acid Antagonists - therapeutic use | Stem Cell Transplantation | Topoisomerase Inhibitors - pharmacology | Thalidomide - analogs & derivatives | Diphtheria Toxin - therapeutic use | Topoisomerase Inhibitors - therapeutic use | Immunoconjugates - therapeutic use | Antineoplastic Agents - pharmacology | Depsipeptides - therapeutic use | Prednisolone - therapeutic use | Lymphoma, T-Cell, Peripheral - drug therapy | Antibodies, Monoclonal, Humanized - therapeutic use | Alemtuzumab | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, T-Cell, Peripheral - pathology | Vincristine - therapeutic use | Histone Deacetylase Inhibitors - therapeutic use | Lymphoma, T-Cell, Peripheral - therapy | Thalidomide - therapeutic use | Folic Acid Antagonists - pharmacology | Care and treatment | Lymphomas | T cells | Health aspects | Index Medicus
Journal Article
British journal of pharmacology, ISSN 0007-1188, 02/2010, Volume 159, Issue 4, pp. 842 - 855
Background and purpose:  Apremilast is an orally administered phosphodiesterase-4 inhibitor, currently in phase 2 clinical studies of psoriasis and other... 
immunopharmacology | anti-inflammatory drugs | PDE inhibitor | chemokines | inflammation | skin pharmacology | anti‐inflammatory drugs | Skin pharmacology | Inflammation | Anti-inflammatory drugs | Immunopharmacology | Chemokines | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Humans | Middle Aged | Thalidomide - pharmacology | RNA, Messenger - metabolism | Zymosan - metabolism | Thalidomide - analogs & derivatives | Ultraviolet Rays | Psoriasis - pathology | Time Factors | U937 Cells | Anti-Inflammatory Agents - administration & dosage | Skin Transplantation | Cyclic Nucleotide Phosphodiesterases, Type 4 - metabolism | Cytokines - genetics | Keratinocytes - enzymology | Disease Models, Animal | Psoriasis - immunology | Leukocytes, Mononuclear - drug effects | Psoriasis - drug therapy | Administration, Oral | Anti-Inflammatory Agents - pharmacology | Thalidomide - administration & dosage | Skin - enzymology | Keratinocytes - immunology | Killer Cells, Natural - enzymology | Keratinocytes - drug effects | Lipopolysaccharides - pharmacology | Killer Cells, Natural - drug effects | Mice | Transplantation, Heterologous | Dose-Response Relationship, Drug | Psoriasis - genetics | Enterotoxins - immunology | Leukocytes, Mononuclear - immunology | Inflammation Mediators - metabolism | Phosphodiesterase 4 Inhibitors | Killer Cells, Natural - immunology | Adult | Skin - pathology | Skin - immunology | Severity of Illness Index | Cytokines - metabolism | Phosphodiesterase Inhibitors - pharmacology | Mice, SCID | Gene Expression Regulation - drug effects | Phosphodiesterase Inhibitors - administration & dosage | Animals | Skin - radiation effects | Leukocytes, Mononuclear - enzymology | Cell Proliferation - drug effects | Psoriasis - enzymology | Skin - drug effects | Psoriasis | Tumor necrosis factor-TNF | Rodents | Index Medicus | Research Papers
Journal Article